SCHEMBL6902050

SCHEMBL6902050

CCN1C(C)CCCC1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.39
MGLL Q99685 1/20 0.36
HRH3 Q9Y5N1 2/20 0.34
HRH2 P25021 1/20 0.34
HRH1 P35367 1/20 0.34
MAOB P27338 1/20 0.34
LTA4H P09960 1/20 0.33
RECQL P46063 1/20 0.33
ALDH1A1 P00352 4/20 0.32
TSHR P16473 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HSD17B10 Q99714 1/20 0.32
THRB P10828 1/20 0.32
POLB P06746 1/20 0.31
HPGD P15428 3/20 0.31
GLA P06280 1/20 0.31
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
GFER P55789 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3543013 1.00 ACHE (0.39) ACHEMGLLHRH3HRH2HRH1
SCHEMBL13407651 1.00 ACHE (0.39) ACHEMGLLHRH3HRH2HRH1
SCHEMBL19529324 0.88
SCHEMBL4746456 0.88
SCHEMBL13674461 0.88
SCHEMBL25512114 0.83 ACHE (0.32) ACHEMGLLHRH3HRH2HRH1
SCHEMBL20352144 0.81
SCHEMBL19067245 0.79 MGLL (0.32) ACHEMGLL
SCHEMBL1286680 0.78 HRH3 (0.39) ACHEHRH3HRH2HRH1MAOB
SCHEMBL19074420 0.78 HRH3 (0.39) ACHEHRH3HRH2HRH1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115335416-A Method for polymerizing at least one radically polymerizable compound 博斯蒂克股份公司 2022-11-11 CN claimed
CN-110467200-A A kind of Cu-SSZ-39 molecular sieve and its preparation method and application RES CT FOR ECO ENVIRONMENTAL SCIENCES CAS 2019-11-19 CN claimed
CN-105314646-B AEI type Si-Al molecular sieves and its preparation method and application 南京开丽环保材料有限公司 2018-06-08 CN claimed
EP-3286163-A1 METHOD FOR PREPARING STRUCTURED DIRECTING AGENT Johnson Matthey Public Limited Company (GB) 2018-02-28 EP claimed
US-20180016231-A9 METHOD FOR PREPARING STRUCTURED DIRECTING AGENT JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2018-01-18 US claimed
WO-2016172128-A1 METHOD FOR PREPARING STRUCTURED DIRECTING AGENT JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2016-10-27 WO claimed
US-20160304457-A1 METHOD FOR PREPARING STRUCTURED DIRECTING AGENT JOHNSON MATTHEY PLC (GB) 2016-10-20 US claimed
CN-105314646-A AEI-type aluminosilicate molecular sieves, and preparation methods and applications thereof SUN HONG 2016-02-10 CN claimed
CN-105315195-A Template agent and preparation method therefor and application thereof SUN HONG 2016-02-10 CN claimed
WO-2025125027-A1 METHOD FOR SYNTHESISING AN IZM-10 AEI ZEOLITE HAVING A VERY HIGH PURITY IN THE PRESENCE OF A NITROGEN-CONTAINING ORGANIC STRUCTURING AGENT IFP Energies Nouvelles (FR) 2025-06-19 WO disclosed
WO-2025125026-A1 SYNTHESIS OF A CATALYST COMPRISING AN IZM-10 AEI ZEOLITE AND AT LEAST ONE TRANSITION METAL FOR THE SELECTIVE REDUCTION OF NOX IFP Energies Nouvelles (FR) 2025-06-19 WO disclosed
CN-119213168-A Boron-containing precursors for ALD deposition of boron nitride films 弗萨姆材料美国有限责任公司 2024-12-27 CN disclosed
CN-118724012-A Molecular sieve and preparation method thereof 中化学科学技术研究有限公司 2024-10-01 CN disclosed
US-11912723-B2 KRAS modulators and uses thereof QUANTA THERAPEUTICS, INC. (US) 2024-02-27 US disclosed
WO-2009133348-A1 AMINOPYRIDINE DERIVATIVES VANTIA LIMITED (GB) 2009-11-05 WO disclosed
US-20090137561-A1 Substituted biphenyl GPR40 modulators AMGEN INC. (US) 2009-05-28 US disclosed
US-3988342-A TRANQUILIZERS MERCK & CO., INC. (US) 1976-10-26 US disclosed
US-3981877-A APPETITE STIMULANTS MERCK & CO., INC. (US) 1976-09-21 US disclosed
US-3981876-A ANTIHISTAMINES, APPETITE STIMULANTS MERCK & CO., INC. (US) 1976-09-21 US disclosed
US-3968115-A OR 11)-BROMO-10,11-DIHYDRO-5H-DIBENZO(A,D)-CYCLOHEPTEN-5-YLIDENE PIPERIDINE COMPOUNDSANTIHISTAMINE, APPETITE STIMULANT MERCK & CO., INC. (US) 1976-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137561-A1 Substituted biphenyl GPR40 modulators GPR119, GPR65, GPR55 ACHE 4395/4885MGLL 400/4885HRH3 1239/4885
US-20180016231-A9 METHOD FOR PREPARING STRUCTURED DIRECTING AGENT SDAD1, ARSA, STS ACHE 930/4885MGLL 418/4885HRH3 1783/4885
US-20160304457-A1 METHOD FOR PREPARING STRUCTURED DIRECTING AGENT SDAD1, ARSA, STS ACHE 930/4885MGLL 418/4885HRH3 1783/4885
US-11912723-B2 KRAS modulators and uses thereof KRAS, NRAS, HRAS ACHE 4805/4885MGLL 2892/4885HRH3 2573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.